Literature DB >> 3088083

Conditional deficiencies of ornithine or arginine.

L Zieve.   

Abstract

Relative deficiencies of ornithine or arginine occur in the presence of excessive ammonia, excessive lysine, growth, pregnancy, trauma, or protein deficiency and malnutrition. Ammonia excess may occur in the presence of a normal liver when amino acid mixtures lacking ornithine, arginine, or citrulline are infused; when specific amino acids such as glycine are injected; when ammonium salts, urea, or urease are injected; or when the gastrointestinal tract contains an excess of protein, urea, or NH4+, as occurs after a gastrointestinal hemorrhage. In these states, ornithine is often rate-limiting for urea cycle function. Ornithine is also rate-limiting when ammonia excess occurs in the presence of hepatic failure. In three of the inherited urea cycle disorders, ornithine insufficiency and ammonia excess also occur. These disorders are citrullinemia, argininosuccinic aciduria, and argininemia. In the presence of excessive lysine the availability of arginine is reduced and the formation of ornithine is decreased in the liver; urea synthesis is reduced, but orotic acid synthesis is increased, and orotic aciduria results as carbamyl phosphate is directed toward the pyrimidine pathway. Hereditary lysinuric protein intolerance results in ornithine depletion, hyperammonemia, and orotic acid uria. Optimal growth in several species of animals requires 0.4-1.0% arginine in the diet. Diets deficient in arginine are associated with poor wound healing as well as stunted growth. The measurement of orotic acid excretion has been a convenient indicator of insufficiency of ornithine or arginine during growth or pregnancy in animals and should prove useful in assessing the requirement for arginine after trauma. Normal human pregnancy is associated with low-grade orotic aciduria. Protein deficiency and malnutrition increase the vulnerability of the animal or child to ammonia toxicity. This is presumably due to insufficient ornithine for normal urea cycle responsiveness.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088083     DOI: 10.1080/07315724.1986.10720123

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  7 in total

1.  B and T cell immunity in patients with lysinuric protein intolerance.

Authors:  M Lukkarinen; K Parto; O Ruuskanen; O Vainio; H Käyhty; R M Olander; O Simell
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Decreased hyperammonaemia and orotic aciduria due to inactivation of ornithine aminotransferase in mice with a hereditary abnormal ornithine carbamoyltransferase.

Authors:  N Seiler; C Grauffel; G Daune-Anglard; S Sarhan; B Knödgen
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

3.  Studies of ammonia loading: effects of rate of delivery and enhanced removal of NH4 on blood levels of ammonia and coma induction.

Authors:  L Zieve; D Charboneau; C Lyftogt
Journal:  Metab Brain Dis       Date:  1989-06       Impact factor: 3.584

Review 4.  Endogenous ornithine in search for CNS functions and therapeutic applications.

Authors:  N Seiler; G Daune-Anglard
Journal:  Metab Brain Dis       Date:  1993-09       Impact factor: 3.584

5.  Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets.

Authors:  L Castillo; T E Chapman; M Sanchez; Y M Yu; J F Burke; A M Ajami; J Vogt; V R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

6.  Protection against lethal ammonia intoxication: synergism between endogenous ornithine and L-carnitine.

Authors:  S Sarhan; B Knoedgen; N Seiler
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

7.  Acute effects of Nitrosigine® and citrulline malate on vasodilation in young adults

Authors:  Jeffrey M Rogers; Joshua Gills; Michelle Gray
Journal:  J Int Soc Sports Nutr       Date:  2020-02-24       Impact factor: 5.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.